What's in Charleston Laboratories, Inc's pipeline?

Charleston Laboratories, Inc has 4 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 1 in Phase 1.

Which companies overlap with Charleston Laboratories, Inc's portfolio?

Top competitors by shared drug class: TWi Biotechnology, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/charleston-laboratories-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Charleston Laboratories, Inc — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Charleston Laboratories, Inc pipeline: 1 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 1 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Vicoprofen	Vicoprofen	marketed			Other
CL-108	CL-108	phase 3	TRPM8 receptor antagonist	TRPM8	Pain management

Therapeutic area mix

Other · 1
Pain · 1
Pain management · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

TWi Biotechnology, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Charleston Laboratories, Inc:

Cite this brief

Drug Landscape (2026). Charleston Laboratories, Inc — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/charleston-laboratories-inc. Accessed 2026-05-16.